局部藥物輸送的全球市場規模、佔有率和成長分析：按類型、按應用分類 - 產業預測（2023-2030）

Global Topical Drug Delivery Market Size, Share, Growth Analysis, By Type(Topical Drug Delivery, Inhalation Drug Delivery), By Application(Cardiovascular Diseases, Respiratory Diseases) - Industry Forecast 2023-2030

出版日期: 2023年10月13日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2021年全球局部給藥市場規模為960億美元，預計將從2022年的1024.3億美元增至2030年的1720.9億美元，年複合成長率預計將成長6.7%。

近年來，市場呈現顯著成長，預計將繼續穩定擴張。痤瘡、牛皮癬、濕疹和皮膚炎等疾病需要有效且有針對性的藥物輸送到受影響的區域。這些皮膚病的盛行率不斷增加，以及對改進治療方案的需求不斷成長，刺激了局部給藥系統的採用。此外，世界人口高齡化也促進了市場擴張。隨著高齡化，關節炎、神經病變疼痛和糖尿病潰瘍等慢性疾病的盛行率增加。局部給藥為治療這些疾病、促進創傷治療和緩解疼痛提供了一種方便、非侵入性的方法。老年人不斷成長的醫療需求正在推動對先進局部給藥系統的需求。局部給藥在輸送活性成分（如類類視色素A和透明質酸）以改善皮膚外觀和對抗老化徵兆方面發揮重要作用。美容皮膚科的日益普及正在刺激創新的局部給藥技術的開發和採用。

全球局部給藥市場的區域考察

全球市場最主要的地區是北美。北美擁有發達的醫療基礎設施、先進的研究設施，且慢性病盛行率較高，對局部給藥系統的需求不斷增加。該地區的特點是製藥公司眾多，並開展了廣泛的以創新藥物輸送技術為重點的研發活動。此外，積極主動的政府配合措施、強力的報銷政策以及先進醫療技術的高採用率也有助於北美在全球市場上佔據主導地位。

全球局部藥物傳輸市場動態

全球局部給藥市場的促進因素

方便、非侵入性

局部給藥提供了一種方便、非侵入性的給藥方法，並且無需注射或口服藥物。此功能對於害怕針頭或喜歡更舒適、無麻煩的方法的患者特別有益。局部製劑的使用可以提高治療醫囑遵從性和整體患者體驗，使其成為首選，特別是對於兒童和有針恐懼症的患者。

全球局部給藥市場的抑制因素

配方挑戰

開發穩定有效的外用製劑面臨重大挑戰。藥物溶解度、穩定性、與賦形劑的相容性以及實現所需釋放曲線等各種因素導致製劑開發的複雜性。這些配方挑戰可能會影響外用藥物的可得性和商業性可行性，因為配方必須滿足嚴格的品質標準和法規要求，同時確保最佳治療效果。

全球給藥市場趨勢

老年族群的皮膚病：皮膚病患病率的增加、老年人口的增加以及對非侵入性給藥方法的需求不斷成長正在推動市場的發展。此外，微針和奈米載體等新的局部藥物傳輸技術的開發也有望促進市場成長。然而，局部給藥產品的高價格和嚴格的法規要求可能會抑制市場成長。

本報告針對全球局部給藥市場進行研究與分析，提供市場動態與前景、細分市場分析、公司簡介等。

Johnson & Johnson (US)
Novartis AG (Switzerland)
GlaxoSmithKline plc (United Kingdom)
Pfizer Inc. (US)
Bayer AG (Germany)
Sanofi SA (France)
Merck & Co., Inc. (US)
Eli Lilly and Company (US)
AstraZeneca PLC (United Kingdom)
Gilead Sciences, Inc. (US)
Teva Pharmaceutical Industries Ltd. (Israel)
Sun Pharmaceutical Industries Ltd. (India)
LEO Pharma A/S (Denmark)
Perrigo Company plc (Ireland)
Mylan NV (US)
Galderma SA (Switzerland)
Glenmark Pharmaceuticals Ltd. (India)
Almirall, SA (Spain)
Dermira, Inc. (US)
Fougera Pharmaceuticals Inc. (US)

簡介目錄

Product Code: SQMIG35D2106

Global Topical Drug Delivery Market size was valued at USD 96 billion in 2021 and is poised to grow from USD 102.43 billion in 2022 to USD 172.09 billion by 2030, growing at a CAGR of 6.7% in the forecast period (2023-2030).

The global topical drug delivery market has experienced significant growth in recent years and is expected to continue expanding at a steady pace. Conditions like acne, psoriasis, eczema, and dermatitis require effective and targeted drug delivery to the affected areas. The rising incidence of these skin ailments, coupled with the growing demand for improved treatment options, has fueled the adoption of topical drug delivery systems. Moreover, the ageing population worldwide has contributed to the market expansion. As individuals age, the prevalence of chronic conditions such as arthritis, neuropathic pain, and diabetic ulcers increases. Topical drug delivery offers a non-invasive and convenient approach for managing these conditions, promoting wound healing, and providing pain relief. The elderly population's rising healthcare needs have driven the demand for advanced topical drug delivery systems. Topical drug delivery plays a crucial role in delivering active ingredients, such as retinoids and hyaluronic acid, to enhance skin appearance and combat ageing signs. The growing popularity of cosmetic dermatology has fueled the development and adoption of innovative topical drug delivery technologies.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Topical Drug Delivery Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Topical Drug Delivery Market Segmental Analysis

The global topical drug delivery market is segmented by type, application, and region. Based on type, the market can be segmented into Topical Drug Delivery, Inhalation Drug Delivery, Injectable Drug Delivery, and Oral Drug Delivery. Based on application, the market is segmented Cardiovascular Diseases, Respiratory Diseases, Diabetes, Oncology, and Central Nervous System (CNS) Disorders. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Topical Drug Delivery Market Regional Insights

In the global topical drug delivery market, the most dominant region is North America. North America has a well-established healthcare infrastructure, advanced research facilities, and a high prevalence of chronic diseases, driving the demand for topical drug delivery systems. The region is characterised by a strong presence of pharmaceutical companies and extensive R&D activities focused on innovative drug delivery technologies. Additionally, favourable government initiatives, robust reimbursement policies, and a high adoption rate of advanced healthcare technologies contribute to the dominance of North America in the global topical drug delivery market.

Global Topical Drug Delivery Market Dynamics

Drivers of the Global Topical Drug Delivery Market

Convenience and Non-Invasiveness

Topical drug delivery offers a convenient and non-invasive method of administering medications, eliminating the requirement for injections or oral medications. This feature is particularly advantageous for patients who may have a fear of needles or prefer a more comfortable and hassle-free approach. The use of topical formulations enhances treatment adherence and overall patient experience, making it a preferred option, especially for children and individuals with needle phobia.

Restraints In the Global Topical Drug Delivery Market

Formulation Challenges

The development of stable and effective topical formulations can present significant challenges. Various factors, including drug solubility, stability, compatibility with excipients, and achieving the desired release profile, contribute to the complexity of formulation development. These formulation challenges can impact the availability and commercial viability of topical drug products, as the formulation must meet stringent quality standards and regulatory requirements while ensuring optimal therapeutic efficacy.

Market Trends of the Global Topical Drug Delivery Key

Skin Issues among the Aging Population: The market is driven by the increasing prevalence of skin diseases, the rising ageing population, and the growing demand for non-invasive drug delivery methods. The development of new topical drug delivery technologies, such as microneedles and nanocarriers, is also expected to boost the market growth. However, the high cost of topical drug delivery products and the stringent regulatory requirements could restrain the market growth.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Topical Drug Delivery Market by Type
- Market Overview
- Topical Drug Delivery
- Inhalation Drug Delivery
- Injectable Drug Delivery and Oral Drug Delivery.
Global Topical Drug Delivery Market by Application
- Market Overview
- Cardiovascular Diseases
- Respiratory Diseases
- Diabetes
- Oncology and Central Nervous System (CNS) Disorders.
Global Topical Drug Delivery Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Johnson & Johnson (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Novartis AG (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- GlaxoSmithKline plc (United Kingdom)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Pfizer Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Bayer AG (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sanofi S.A. (France)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Merck & Co., Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Eli Lilly and Company (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- AstraZeneca PLC (United Kingdom)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Gilead Sciences, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Teva Pharmaceutical Industries Ltd. (Israel)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sun Pharmaceutical Industries Ltd. (India)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- LEO Pharma A/S (Denmark)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Perrigo Company plc (Ireland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Mylan N.V. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Galderma S.A. (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Glenmark Pharmaceuticals Ltd. (India)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Almirall, S.A. (Spain)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Dermira, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Fougera Pharmaceuticals Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments